Search clinical trials for: Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing

Total 54044 results

Novartis Pharmaceuticals

Terminated

Study of Tolerability and Efficacy of BVS857 in Severe Burn Subjects

Hypercatabolic Status Related to Severe Burn

United States
The University of Texas Medical Branch, Galveston
Pfizer; United States Department of Defense

Completed

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

Burns | Growth Hormone Treatment

United States
Qassim University
Cairo University

Completed

Xbox Kinect Promote Physical Fitness and Lean Mass in Severely Burned Children (XboxBurn)

Burns
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Recruiting

Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome

Dengue Fever

Bangladesh
Tongji Hospital

Recruiting

A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome

Severe Fever With Thrombocytopenia Syndrome

China
ReAlta Life Sciences, Inc.
Premier Research Group plc

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia (STAR)

Hypoxic-Ischemic Encephalopathy

United States
Romanian Society for Enteral and Parenteral Nutrition

Not yet recruiting

ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts (ACCUMULATE)

Trauma | Gastroparesis | Muscle Loss | Metabolism | Nutritional Deficiency | Protein Malnutrition | Calorie Malnutrition Protein

Romania
Qin Ning

Recruiting

Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)

Severe Fever With Thrombocytopenia Syndrome

China
Hunan Provincial People's Hospital

Recruiting

Targeted Shortwave Diathermy Combined With Perceptual Training for Patients With Severe Traumatic Optic Neuropathy

Traumatic Optic Neuropathy

China
University Hospital, Lille
Ministry of Health, France

Recruiting

DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision Rule (DISCERN-FN7)

Neutropenia, Febrile

France
North Florida Foundation for Research and Education
University of Florida; Brooks Rehabilitation; North Florida/South Georgia Veterans...

Recruiting

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Central Nervous System Diseases | Nervous System Diseases | Wounds and Injuries | Endocrine System Diseases | Gonadal Disorders | Trauma, Nervous System | Spinal Cord Diseases | Hypogonadism | Spinal Cord Injuries | Gait Disorders, Neurologic | Spinal Cord Injury | Wounds and Injury | Testosterone Deficiency | Hormone... and other conditions

United States
Azienda Ospedaliera, Ospedale Civile di Legnano
Acelity

Not yet recruiting

CiNPT for Abdominoplasties in Post-bariatric Patients Study (CAPS)

Obesity | Obesity, Morbid | Surgery--Complications | Surgical Wound Infection | Surgical Site Infection | Wound Infection | Scar | Wound Heal | Obesity, Abdominal | Wound | Wound Contamination | Wound Complication | Scarring | Wound Dehiscence | Incision | Wound; Abdomen | Incision Site Rash | Incision Site Bleeding | Incision Site... and other conditions
University of Calgary

Recruiting

SMOFlipid and Incidence of BPD in Preterm Infants

Bronchopulmonary Dysplasia | Very Low Birth Weight Infant

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Obesity | Malignant Breast Neoplasm | Body Mass Index Greater Than or Equal to 30 | Mammoplasty Patient

United States
Paul Szabolcs

Recruiting

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis (SSc)

Systemic Sclerosis | Pulmonary Hypertension | Interstitial Lung Disease | Diffuse Sclerosis Systemic

United States
Universität Duisburg-Essen

Completed

Whole-body Hyperthermia for Moderate to Severe Depressive Disorder (HYPE2)

Depression, Unipolar

Germany
VA Office of Research and Development
University of Florida

Terminated

Testosterone Plus Finasteride Treatment After Spinal Cord Injury

Central Nervous System Diseases | Nervous System Diseases | Wounds and Injuries | Endocrine System Diseases | Gonadal Disorders | Trauma, Nervous System | Spinal Cord Diseases | Hypogonadism | Spinal Cord Injuries | Spinal Cord Injury | Genital Diseases, Male

United States
Enzychem Lifesciences Corporation

Completed

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Febrile Neutropenia

Korea, Republic of
The University of Texas Medical Branch, Galveston
National Institute of General Medical Sciences (NIGMS)

Completed

Assessment of Mechanisms of Improved Wound Healing

Burns

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Human Immunodeficiency Virus | Dengue Fever | Dengue Hemorrhagic Fever

Brazil
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

Dengue Fever | Dengue Hemorrhagic Fever

Brazil, Mexico
Albert B. Sabin Vaccine Institute
ICON plc; Oklahoma Blood Institute

Completed

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Ebola Virus Disease | Marburg Virus Disease

United States
Hospices Civils de Lyon

Completed

Warm-up Efficiency by Body Warmer Versus Standard Procedure in Severely Traumatized Patients (THERMOTRAUMA)

Hypothermia | Trauma, Psychological

France
Sanofi Pasteur, a Sanofi Company

Completed

Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine

Dengue Fever | Dengue Haemorrhagic Fever

Thailand
Central Hospital, Nancy, France

Completed

Trajectories of Resilience and Bariatric Surgery Outcomes (ECLAIRCIE)

Psychological Distress | Bariatric Surgery Candidate | Severe Obesity

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Disease

Vietnam
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Peru
Sanofi Pasteur, a Sanofi Company

Completed

Efficacy and Safety of Dengue Vaccine in Healthy Children

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

India
Sanofi Pasteur, a Sanofi Company

Completed

Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Dengue Fever | Dengue Hemorrhagic Fever | Human Papillomavirus Disease

Malaysia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Dengue Fever | Dengue Hemorrhagic Fever | Human Papillomavirus Disease

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Yellow Fever | Dengue | Dengue Hemorrhagic Fever

Peru, Colombia
Sanofi Pasteur, a Sanofi Company

Terminated

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

Dengue Fever | Dengue Hemorrhagic Fever

Philippines
Sanofi

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

Dengue Fever | Dengue Hemorrhagic Fever

Malaysia
Sanofi Pasteur, a Sanofi Company

Completed

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

Yellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic Fever

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Dengue Fever | Dengue Hemorrhagic Fever

Colombia, Philippines
Sanofi Pasteur, a Sanofi Company
United States Department of Defense

Completed

Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule

Dengue Fever | Dengue Hemorrhagic Fever

Brazil, Colombia, Honduras, Mexico, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Dengue | Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus

Puerto Rico, Colombia, Mexico, Honduras
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Dengue Fever | Dengue Hemorrhagic Fever

Singapore
Sanofi Pasteur, a Sanofi Company

Completed

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Singapore
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

Indonesia, Philippines, Malaysia, Thailand, Vietnam
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

Colombia, Puerto Rico, Brazil, Honduras, Mexico
Rutgers University
National Institute on Aging (NIA)

Terminated

The Effect of Severe Weight Loss and Protein Intake on Bone

Weight Loss

United States
McGill University

Terminated

Can Correction of Low Vitamin D Status in Infancy Program for a Leaner Body Composition?

Healthy | Vitamin D Deficiency | Gestational Diabetes

Canada
Cairo University

Completed

Protein Supplementation and Exercise Training in Burn Patients

Burns

Egypt
RenJi Hospital
Xiangya Hospital of Central South University; West China Hospital; Qilu Hospital... and other collaborators

Completed

Randomized Controlled Trial of Long-term Mild Hypothermia for Severe Traumatic Brain Injury (LTH-Ⅰ)

Brain Injuries | Craniocerebral Trauma

China
Krishnadevaraya College of Dental Sciences & Hospital

Unknown

Comparative Evaluation of Various Patient Centered Outcomes Following Gingival Depigmentation Using Diode LASER in Different Modes: A Randomized Clinical Trial (LASER)

Pain, Postoperative | Analgesia | Temperature Change, Body | Healing Surgical Wounds

India
University of Sao Paulo General Hospital

Unknown

Effects of EMDR Therapy in Patients With Severe Obesity

Obesity | Emotional Trauma

Brazil

Search clinical trials for: Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations